- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder
This is a Virtual Event for PsychU members in Alabama and Florida.
Bipolar I Disorder is characterized by mood episode recurrence, which impacts patient functioning and clinical outcomes. During our discussion, speakers will discuss risk factors for mood recurrence including non-adherence. They will also discuss some management strategies including long acting injectables (LAIs) that may optimize patient outcomes.

Beau Pender, PharmD
Medical Science Liaison

Rohona Masharak, PHMNP-BC, MSL (OPDC)
Medical Science Liaison
Speakers Beau Pender, PharmD and Rohona Masharak, PHMNP-BC, MSL are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)